Anthony Post is a Gastroenterology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 79 publications with 2,005 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Ave
Cleveland, OH 441061716
Telephone
216-844-8500Provider last certified this registry record 14 Jan 2021.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment
- Gilead Sciences, Inc.Program year20251 payment
- Madrigal PharmaceuticalsProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
37.1%Bile Acid10.7%Ursodiol100%Part D≥21 patientsProton pump inhibitor8.2%Pantoprazole Sodium58%Omeprazole42%Part D<11 patients+ 3 more classes in this area
Cardiovascular
26%Loop diuretic8.4%Furosemide68%Bumetanide32%Part D<11 patientsAldosterone antagonist (MRA)8%Spironolactone100%Part D≥15 patients+ 2 more classes in this area
Cancer & immunology
20.6%Calcineurin inhibitor20.6%Tacrolimus82%Cyclosporine Modified18%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1994–1994 per NIH RePORTER. The latest:
- LIDOCAINE METABOLISM AS MEASURE OF LIVER FUNCTION FOR LIVER TRANSPLANTATION
Case Western Reserve University
FY1994M01RR000080
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis
Digestive Diseases and Sciences
2017 - Alpha-fetoprotein-producing esophageal adenocarcinoma: a mimicker of hepatocellular carcinoma
Clinical Journal of Gastroenterology
2016 - Hepatitis C Treatment as a Possible Cause of Acute Pancreatic Transplant Rejection
The American Journal of Gastroenterology
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Lederman, MD
University Hospitals of Cleveland
Anthony Furlan
University Hospitals of Cleveland
Joseph Sabik, MD
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”